Clinical trial
Prophylaxis for Emetogenic radioTherapy With Akynzeo
NCT07882966 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylaxis for Emetogenic radioTherapy With Akynzeo
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- November 1, 2028
- Enrollment
- 188 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
palliative cancer